Raymond Townsend, Director at Kindred Biosciences, Inc. (KIN), sold 91 shares at $9.45 ($860) on 2018-03-12, disclosed to the SEC on 2018-03-14.
Scheduled sale ($860) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KIN | SELL | 2018-01-04 | $121K | — | Filing → |
| KIN | BUY | 2015-11-24 | $8K | — | Filing → |
| KIN | BUY | 2015-11-19 | $11K | — | Filing → |